全文获取类型
收费全文 | 8548篇 |
免费 | 602篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 225篇 |
妇产科学 | 396篇 |
基础医学 | 945篇 |
口腔科学 | 188篇 |
临床医学 | 1042篇 |
内科学 | 1734篇 |
皮肤病学 | 77篇 |
神经病学 | 713篇 |
特种医学 | 330篇 |
外科学 | 1099篇 |
综合类 | 240篇 |
一般理论 | 4篇 |
预防医学 | 479篇 |
眼科学 | 180篇 |
药学 | 729篇 |
中国医学 | 84篇 |
肿瘤学 | 737篇 |
出版年
2023年 | 45篇 |
2022年 | 108篇 |
2021年 | 179篇 |
2020年 | 106篇 |
2019年 | 177篇 |
2018年 | 215篇 |
2017年 | 175篇 |
2016年 | 175篇 |
2015年 | 245篇 |
2014年 | 284篇 |
2013年 | 379篇 |
2012年 | 547篇 |
2011年 | 620篇 |
2010年 | 412篇 |
2009年 | 351篇 |
2008年 | 505篇 |
2007年 | 513篇 |
2006年 | 530篇 |
2005年 | 465篇 |
2004年 | 399篇 |
2003年 | 331篇 |
2002年 | 299篇 |
2001年 | 273篇 |
2000年 | 230篇 |
1999年 | 200篇 |
1998年 | 90篇 |
1997年 | 82篇 |
1996年 | 77篇 |
1995年 | 57篇 |
1994年 | 50篇 |
1993年 | 49篇 |
1992年 | 115篇 |
1991年 | 118篇 |
1990年 | 101篇 |
1989年 | 82篇 |
1988年 | 80篇 |
1987年 | 81篇 |
1986年 | 48篇 |
1985年 | 43篇 |
1984年 | 37篇 |
1983年 | 37篇 |
1982年 | 28篇 |
1981年 | 27篇 |
1980年 | 21篇 |
1979年 | 28篇 |
1978年 | 33篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1974年 | 26篇 |
1968年 | 18篇 |
排序方式: 共有9266条查询结果,搜索用时 31 毫秒
131.
132.
Nobiletin,a Polymethoxylated Flavone,Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways
下载免费PDF全文
![点击此处可从《Phytotherapy research : PTR》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Ray‐Jade Chen Hou‐Chang Chiu Jia‐Lun Wu Ming‐Yi Shen Duen‐Suey Chou Joen‐Rong Sheu Kuan‐Hung Lin Wan‐Jung Lu 《Phytotherapy research : PTR》2016,30(2):214-221
Nobiletin, a bioactive polymethoxylated flavone (5,6,7,8,3',4'‐hexamethoxyflavone), is abundant in citrus fruit peel. Although nobiletin exhibits antitumor activity against various cancer cells, the effect of nobiletin on glioma cells remains unclear. The aim of this study was to determine the effects of nobiletin on the human U87 and Hs683 glioma cell lines. Treating glioma cells with nobiletin (20–100 µm ) reduced cell viability and arrested the cell cycle in the G0/G1 phase, as detected using a 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide assay and propidium iodide (PI) staining, respectively; however, nobiletin did not induce cell apoptosis according to PI‐annexin V double staining. Data from western blotting showed that nobiletin significantly attenuated the expression of cyclin D1, cyclin‐dependent kinase 2, cyclin‐dependent kinase 4, and E2 promoter‐binding factor 1 (E2F1) and the phosphorylation of Akt/protein kinase B and mitogen‐activated protein kinases, including p38, extracellular signal‐regulated kinase, and c‐Jun N‐terminal kinase. Our data also showed that nobiletin inhibited glioma cell migration, as detected by both functional wound healing and transwell migration assays. Altogether, the present results suggest that nobiletin inhibits mitogen‐activated protein kinase and Akt/protein kinase B pathways and downregulates positive regulators of the cell cycle, leading to subsequent suppression of glioma cell proliferation and migration. Our findings evidence that nobiletin may have potential for treating glioblastoma multiforme. Copyright © 2015 John Wiley & Sons, Ltd. 相似文献
133.
Christoph F. Dietrich Adrian Goudie Liliana Chiorean Xin Wu Cui Odd Helge Gilja Yi Dong Jacques S. Abramowicz Sudhir Vinayak Susan Campbell Westerway Christian Pállson Nolsøe Yi-Hong Chou Michael Blaivas 《Ultrasound in medicine & biology》2017,43(1):49-58
Over the last decade, the use of portable ultrasound scanners has enhanced the concept of point of care ultrasound (PoC-US), namely, “ultrasound performed at the bedside and interpreted directly by the treating clinician.” PoC-US is not a replacement for comprehensive ultrasound, but rather allows physicians immediate access to clinical imaging for rapid and direct solutions. PoC-US has already revolutionized everyday clinical practice, and it is believed that it will dramatically change how ultrasound is applied in daily practice. However, its use and teaching are different from continent to continent and from country to country. This World Federation for Ultrasound in Medicine and Biology position paper discusses the current status and future perspectives of PoC-US. Particular attention is given to the different uses of PoC-US and its clinical significance, including within emergency and critical care medicine, cardiology, anesthesiology, rheumatology, obstetrics, neonatology, gynecology, gastroenterology and many other applications. In the future, PoC-US will be more diverse than ever and be included in medical student training. 相似文献
134.
Ming‐Chun Hsieh Yu‐Cheng Ho Cheng‐Yuan Lai Dylan Chou Hsueh‐Hsiao Wang Gin‐Den Chen Tzer‐Bin Lin Hsien‐Yu Peng 《Journal of pineal research》2017,63(4)
Melatonin (N‐acetyl‐5‐methoxytryptamine)/MT2 receptor‐dependent epigenetic modification represents a novel pathway in the treatment of neuropathic pain. Because spinal ten‐eleven translocation methylcytosine dioxygenase 1 (Tet1)‐dependent epigenetic demethylation has recently been linked to pain hypersensitivity, we hypothesized that melatonin/MT2‐dependent analgesia involves spinal Tet1‐dependent demethylation. Here, we showed that spinal Tet1 gene transfer by intrathecal delivery of Tet1‐encoding vectors to naïve rats produced profound and long‐lasting nociceptive hypersensitivity. In addition, enhanced Tet1 expression, Tet1‐metabotropic glutamate receptor subtype 5 (mGluR5) promoter coupling, demethylation at the mGluR5 promoter, and mGluR5 expression in dorsal horn neurons were observed. Rats subjected to spinal nerve ligation and intraplantar complete Freund's adjuvant injection displayed tactile allodynia and behavioral hyperalgesia associated with similar changes in the dorsal horn. Notably, intrathecal melatonin injection reversed the protein expression, protein‐promoter coupling, promoter demethylation, and pain hypersensitivity induced by Tet1 gene transfer, spinal nerve ligation, and intraplantar complete Freund's adjuvant injection. All the effects caused by melatonin were blocked by pretreatment with a MT2 receptor‐selective antagonist. In conclusion, melatonin relieves pain by impeding Tet1‐dependent demethylation of mGluR5 in dorsal horn neurons through the MT2 receptor. Our findings link melatonin/MT2 signaling to Tet1‐dependent epigenetic demethylation of nociceptive genes for the first time and suggest melatonin as a promising therapy for the treatment of pain. 相似文献
135.
136.
S. S. Meshaal R. E. El Hawary D. S. Abd Elaziz A. Eldash R. Alkady S. Lotfy A. A. Mauracher L. Opitz J. Pachlopnik Schmid M. van der Burg J. Chou N. M. Galal J. A. Boutros R. Geha A. M. Elmarsafy 《Clinical and experimental immunology》2019,195(2):202-212
Mutations affecting recombination activation genes RAG1 and RAG2 are associated with variable phenotypes, depending on the residual recombinase activity. The aim of this study is to describe a variety of clinical phenotypes in RAG-deficient patients from the highly consanguineous Egyptian population. Thirty-one patients with RAG mutations (from 28 families) were included from 2013 to 2017. On the basis of clinical, immunological and genetic data, patients were subdivided into three groups; classical T–B– severe combined immunodeficiency (SCID), Omenn syndrome (OS) and atypical SCID. Nineteen patients presented with typical T–B–SCID; among these, five patients carried a homozygous RAG2 mutation G35V and five others carried two homozygous RAG2 mutations (T215I and R229Q) that were detected together. Four novel mutations were reported in the T–B–SCID group; three in RAG1 (A565P, N591Pfs*14 and K621E) and one in RAG2 (F29S). Seven patients presented with OS and a novel RAG2 mutation (C419W) was documented in one patient. The atypical SCID group comprised five patients. Two had normal B cell counts; one had a previously undescribed RAG2 mutation (V327D). The other three patients presented with autoimmune cytopaenias and features of combined immunodeficiency and were diagnosed at a relatively late age and with a substantial diagnostic delay; one patient had a novel RAG1 mutation (C335R). PID disorders are frequent among Egyptian children because of the high consanguinity. RAG mutations stand behind several variable phenotypes, including classical SCID, OS, atypical SCID with autoimmunity and T–B+ CID. 相似文献
137.
Currently, tumor necrosis factor alpha (TNF-alpha) inhibitors are widely used for many autoimmune disorders. However, they cause an immunocompromised status that sometimes leads to many cutaneous side effects including atypical infections. Herein, we report the first case of adalimumab-related Majocchi''s granuloma.A 43-year-old Taiwanese male patient with chronic plaque-type psoriasis developed numerous tender nodules 1 month after adalimumab injection. The nodules responded poorly to bacterial folliculitis treatment. After repeated skin biopsies for pathology and tissue fungal culture, Majocchi''s granuloma was confirmed. Adalimumab was withheld, and 12 weeks of terbinafine treatment was given. On completion of treatment, the nodular skin lesions and dystrophic nail lesions improved dramatically.The information, including time span, clinical features, histological findings, and improvement following withdrawal of adalimumab and treatment with an oral antifungal agent, indicates that Majocchi''s granuloma was adalimumab-related. Psoriasis patients are more susceptible to dermatophyte infection due to local and systemic immunosuppressant therapy. It is important to perform a thorough examination for latent dermatophyte infection, including skin and nail lesions, before treatment with TNF-alpha inhibitors and during traditional psoriasis treatment. When atypical presentation together with treatment failure is noted in psoriasis patients prescribed biologics, clinicians should investigate evidence of dermatophyte infection and provide proper treatment. Sometimes, multiple skin biopsies and tissue fungal cultures are required to establish a correct diagnosis. 相似文献
138.
139.
140.